Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study


  • Takeshi Nakahara Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
  • Makiko Kido-Nakahara
  • Daisuke Onozuka
  • Sawako Sakai
  • Tomoko Hirose
  • Nobutoshi Take
  • Akiko Sugiyama
  • Kayo Harada
  • Gaku Tsuji
  • Satoko Kikuchi
  • Futoshi Kohda




atopic dermatitis, dupilumab, eczema area and severity index, itch numerical rating scale, patient-oriented eczema measure


Abstract is missing (Short communication)


Download data is not yet available.


Chello C, Carnicelli G, Sernicola A, Gagliostro N, Paolino G, Di Fraia M, et al. Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature. Int J Dermatol 2020; 59: 716-721.

https://doi.org/10.1111/ijd.14891 DOI: https://doi.org/10.1111/ijd.14891

Silvestre Salvador F, Romero-Pérez D, Encabo-Durán B. Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol 2017; 27: 78-88.

https://doi.org/10.18176/jiaci.0138 DOI: https://doi.org/10.18176/jiaci.0138

Hello M, Aubert H, Bernier C, Néel A, Barbarot S. Atopic dermatitis of the adult. Rev Med Interne 2016; 37: 91-99.

https://doi.org/10.1016/j.revmed.2015.10.345 DOI: https://doi.org/10.1016/j.revmed.2015.10.345

Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes an implications for targeted therapeutics. J Allergy Clin Immunol 2019; 143: 1-11.

https://doi.org/10.1016/j.jaci.2018.10.032 DOI: https://doi.org/10.1016/j.jaci.2018.10.032

Tamagawa-Mineoka R, Katoh N. Atopic dermatitis: identification and management of complicating factors. Int J Mol Sci 2020; 21: 2671.

https://doi.org/10.3390/ijms21082671 DOI: https://doi.org/10.3390/ijms21082671

Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, et al. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol 2021; 185: 139-146.

https://doi.org/10.1111/bjd.19751 DOI: https://doi.org/10.1111/bjd.19751

Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, et al. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol 2016; 175: 69-79.

https://doi.org/10.1111/bjd.14773 DOI: https://doi.org/10.1111/bjd.14773




How to Cite

Nakahara, T., Kido-Nakahara, M., Onozuka, D., Sakai, S., Hirose, T., Take , N., Sugiyama, A., Harada, K., Tsuji, G., Kikuchi, S., & Kohda, F. (2021). Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study. Acta Dermato-Venereologica, 101(11), adv00586. https://doi.org/10.2340/actadv.v101.369



Short Communication